The probabilities for pregnancy rates are outlined in Table 1.> -wrap-foot> For more clinical parameter see Fiddelers et al. supplementary data; RCT: Randomized controlled trial.
When considered together, there does not seem to be a clear association with maternal smoking, OR 1.05 (95% CI 0.98 1.12, and P = 0.20), from 40 studies, with 24 081 malformed controls and 8.2 million controls; Supplementary data, Table S18, Fig. 4e.
There is an association with anal atresia (OR 1.20, 95% CI 1.06 1.36, and P = 0.005, from seven studies (1679 malformed cases, 7.8 million controls); Supplementary data, Table S15, Fig. 4c, and umbilical/inguinal/ventral hernias, OR 1.40 (95% CI 1.23 1.59, and P < 0.00001) from four studies, 941 malformed cases and 374 086 controls; Supplementary data, Table S16, Fig. 4d.
There was no significant induction of the AR (P = 0.6) or of PS externalization (P = 0.6) after continuous incubation with any of the compounds compared with vehicle controls (Supplementary data, Fig. S2).
There is a significant 16% increase in risk associated with maternal smoking (OR 1.16, 95% CI 1.05 1.27, P = 0.002) from 25 studies (41 159 malformed cases, 1.2 million controls); Supplementary data, Table S3 and Fig. 2b.
The pooled OR is 1.15, 95% CI 0.95 1.39, for renal/urinary tract defects, which is not statistically significant (P = 0.15 from 9 studies, 3330 malformed cases and 7.7 million controls; Supplementary data, Table S22 and Fig. S7).
There is a modest (9%) but significant increased risk, OR 1.09 [95% confidence interval (CI) 1.02 1.17, P = 0.009] from 25 studies (29 288 malformed cases, 2.09 million controls); Supplementary data, Table S2a and Fig. 2a.
There is a clear association with gastroschisis, OR 1.50 (95% CI 1.28 1.76), and P < 0.00001, from 12 studies (1822 malformed cases, 2.68 million controls); Supplementary data, Table S13, Fig. 4b).
We found that Gal-3 alstimulatedted cell migration (48.3% above control; P<0.01), but it was less potent compared with Gal-1 (125% above control; P<0.01) (Supplementary Data 2).
After data normalization, intensity signals above background (median log2 signal intensity above 4) could be detected for 22000 probe sets in human control chondrocytes (supplementary data S2).
In addition, the RNA component of the telomerase (TERC) was expressed at very low level in this tumour as compared with the tumours of the control set (Supplementary data S7).
